Sign inGet started

Lippa Arnold

Insider CIK 1363763 · CTRV Director · CORX Executive Chairman and CSO, Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
HEPA Hepion Pharmaceuticals, In A Award deriv2021-05-182021-05-20200,000— $0291,110SEC↗
RSPI RespireRx Pharmaceuticals G Gift deriv2020-09-302020-10-02100— $00SEC↗
RSPI RespireRx Pharmaceuticals J Other deriv2020-09-302020-10-02100— $0100SEC↗
RSPI RespireRx Pharmaceuticals G Gift deriv2020-09-302020-10-02100— $00SEC↗
HEPA Hepion Pharmaceuticals, In A Award deriv2020-08-192020-08-2130,000— $091,110SEC↗
RSPI RespireRx Pharmaceuticals G Gift deriv2020-07-132020-07-15600— $00SEC↗
RSPI RespireRx Pharmaceuticals J Other deriv2020-07-132020-07-15600— $0600SEC↗
RSPI RespireRx Pharmaceuticals G Gift deriv2020-07-132020-07-15600— $00SEC↗
HEPA Hepion Pharmaceuticals, In A Award deriv2020-04-032020-04-0760,000— $061,109SEC↗
RSPI RespireRx Pharmaceuticals G Gift2020-03-222020-03-244,500,000— $0598SEC↗
RSPI RespireRx Pharmaceuticals J Other2020-03-222020-03-244,500,000— $04,500,598SEC↗
HEPA Hepion Pharmaceuticals, In A Award deriv2019-07-242019-07-25970— $01,109SEC↗
RSPI RespireRx Pharmaceuticals G Gift deriv2018-09-122018-09-1447,620— $00SEC↗
RSPI RespireRx Pharmaceuticals P Buy deriv2018-09-122018-09-1447,620— $047,620SEC↗
RSPI RespireRx Pharmaceuticals P Buy2018-09-122018-09-1447,620— $047,620SEC↗
RSPI RespireRx Pharmaceuticals G Gift2018-09-122018-09-1447,620— $00SEC↗
CTRV ContraVir Pharmaceuticals, P Buy deriv2018-07-032018-07-038,625$1000.00 $8.63M8,625SEC↗
CTRV ContraVir Pharmaceuticals, P Buy deriv2018-07-032018-07-0315$1000.00 $15.0K15SEC↗
RSPI RespireRx Pharmaceuticals J Other deriv2017-12-092017-12-12559,595— $0559,595SEC↗
RSPI RespireRx Pharmaceuticals G Gift deriv2017-12-092017-12-12559,595— $00SEC↗
RSPI RespireRx Pharmaceuticals A Award deriv2017-06-302017-07-0550,000— $050,000SEC↗
RSPI RespireRx Pharmaceuticals J Other deriv2017-06-302017-07-0550,000— $00SEC↗
RSPI RespireRx Pharmaceuticals A Award deriv2017-01-182017-01-2050,000— $050,000SEC↗
RSPI RespireRx Pharmaceuticals J Other deriv2017-01-182017-01-2050,000— $00SEC↗
CTRV ContraVir Pharmaceuticals, A Award deriv2016-07-192016-07-2032,500— $077,500SEC↗
RSPI RespireRx Pharmaceuticals J Other deriv2016-06-162016-06-2024,000,000— $00SEC↗
RSPI RespireRx Pharmaceuticals J Other deriv2016-06-162016-06-2010,000,000— $00SEC↗
RSPI RespireRx Pharmaceuticals J Other deriv2016-06-162016-06-2015,000,000— $00SEC↗
RSPI RespireRx Pharmaceuticals A Award deriv2016-03-312016-04-0424,000,000— $024,000,000SEC↗
RSPI RespireRx Pharmaceuticals J Other deriv2016-01-292016-04-043,350,319— $03,350,319SEC↗
CORX CORTEX PHARMACEUTICALS INC A Award deriv2015-08-182015-08-2010,000,000— $010,000,000SEC↗
CORX CORTEX PHARMACEUTICALS INC A Award deriv2015-06-302015-07-0615,000,000— $015,000,000SEC↗
CORX CORTEX PHARMACEUTICALS INC A Award deriv2014-07-172014-07-215,000,000— $05,000,000SEC↗
CORX CORTEX PHARMACEUTICALS INC A Award2014-04-142014-04-1615,000,000— $015,000,000SEC↗
CORX CORTEX PHARMACEUTICALS INC P Buy deriv2014-03-182014-03-20250$1000.00 $250.0K250SEC↗